ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Estradiol Transdermal System Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-0O7293
Home | Market Reports | Health| Medical Devices & Equipment
Global Estradiol Transdermal System Market Insights Forecast to 2028
BUY CHAPTERS

Global Estradiol Transdermal System Market Research Report 2025

Code: QYRE-Auto-0O7293
Report
August 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Allergan plc
Bayer
Noven Therapeutics
Mylan NV
Vertical Pharmaceuticals
Perrigo Pharma International

Estradiol Transdermal System Market Size

The global market for Estradiol Transdermal System was valued at US$ 341 million in the year 2024 and is projected to reach a revised size of US$ 517 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Estradiol Transdermal System Market

Estradiol Transdermal System Market

Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
North American market for Estradiol Transdermal System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Estradiol Transdermal System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Estradiol Transdermal System include Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals, Perrigo Pharma International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Estradiol Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estradiol Transdermal System.
The Estradiol Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Estradiol Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estradiol Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Estradiol Transdermal System Market Report

Report Metric Details
Report Name Estradiol Transdermal System Market
Accounted market size in year US$ 341 million
Forecasted market size in 2031 US$ 517 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 0.025 mg per day
  • 0.0375 mg per day
  • 0.05 mg per day
  • 0.075 mg per day
  • 0.1 mg per day
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals, Perrigo Pharma International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Estradiol Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Estradiol Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Estradiol Transdermal System Market growing?

Ans: The Estradiol Transdermal System Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Estradiol Transdermal System Market size in 2031?

Ans: The Estradiol Transdermal System Market size in 2031 will be US$ 517 million.

Who are the main players in the Estradiol Transdermal System Market report?

Ans: The main players in the Estradiol Transdermal System Market are Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals, Perrigo Pharma International

What are the Application segmentation covered in the Estradiol Transdermal System Market report?

Ans: The Applications covered in the Estradiol Transdermal System Market report are Hot Flashes, Prevention of Postmenopausal Osteoporosis, Treatment of Hypoestrogenism, Moderate-To-Severe Vasomotor Symptoms, Others

What are the Type segmentation covered in the Estradiol Transdermal System Market report?

Ans: The Types covered in the Estradiol Transdermal System Market report are 0.025 mg per day, 0.0375 mg per day, 0.05 mg per day, 0.075 mg per day, 0.1 mg per day

Recommended Reports

Transdermal Systems

Estrogen & Hormones

Women's Health Drugs

1 Estradiol Transdermal System Market Overview
1.1 Product Definition
1.2 Estradiol Transdermal System by Type
1.2.1 Global Estradiol Transdermal System Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.025 mg per day
1.2.3 0.0375 mg per day
1.2.4 0.05 mg per day
1.2.5 0.075 mg per day
1.2.6 0.1 mg per day
1.3 Estradiol Transdermal System by Application
1.3.1 Global Estradiol Transdermal System Market Value by Application (2024 VS 2031)
1.3.2 Hot Flashes
1.3.3 Prevention of Postmenopausal Osteoporosis
1.3.4 Treatment of Hypoestrogenism
1.3.5 Moderate-To-Severe Vasomotor Symptoms
1.3.6 Others
1.4 Global Estradiol Transdermal System Market Size Estimates and Forecasts
1.4.1 Global Estradiol Transdermal System Revenue 2020-2031
1.4.2 Global Estradiol Transdermal System Sales 2020-2031
1.4.3 Global Estradiol Transdermal System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Estradiol Transdermal System Market Competition by Manufacturers
2.1 Global Estradiol Transdermal System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Estradiol Transdermal System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Estradiol Transdermal System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Estradiol Transdermal System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estradiol Transdermal System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estradiol Transdermal System, Product Type & Application
2.7 Global Key Manufacturers of Estradiol Transdermal System, Date of Enter into This Industry
2.8 Global Estradiol Transdermal System Market Competitive Situation and Trends
2.8.1 Global Estradiol Transdermal System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Estradiol Transdermal System Players Market Share by Revenue
2.8.3 Global Estradiol Transdermal System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Estradiol Transdermal System Market Scenario by Region
3.1 Global Estradiol Transdermal System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Estradiol Transdermal System Sales by Region: 2020-2031
3.2.1 Global Estradiol Transdermal System Sales by Region: 2020-2025
3.2.2 Global Estradiol Transdermal System Sales by Region: 2026-2031
3.3 Global Estradiol Transdermal System Revenue by Region: 2020-2031
3.3.1 Global Estradiol Transdermal System Revenue by Region: 2020-2025
3.3.2 Global Estradiol Transdermal System Revenue by Region: 2026-2031
3.4 North America Estradiol Transdermal System Market Facts & Figures by Country
3.4.1 North America Estradiol Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Estradiol Transdermal System Sales by Country (2020-2031)
3.4.3 North America Estradiol Transdermal System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Estradiol Transdermal System Market Facts & Figures by Country
3.5.1 Europe Estradiol Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Estradiol Transdermal System Sales by Country (2020-2031)
3.5.3 Europe Estradiol Transdermal System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estradiol Transdermal System Market Facts & Figures by Region
3.6.1 Asia Pacific Estradiol Transdermal System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Estradiol Transdermal System Sales by Region (2020-2031)
3.6.3 Asia Pacific Estradiol Transdermal System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Estradiol Transdermal System Market Facts & Figures by Country
3.7.1 Latin America Estradiol Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Estradiol Transdermal System Sales by Country (2020-2031)
3.7.3 Latin America Estradiol Transdermal System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Estradiol Transdermal System Market Facts & Figures by Country
3.8.1 Middle East and Africa Estradiol Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Estradiol Transdermal System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Estradiol Transdermal System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estradiol Transdermal System Sales by Type (2020-2031)
4.1.1 Global Estradiol Transdermal System Sales by Type (2020-2025)
4.1.2 Global Estradiol Transdermal System Sales by Type (2026-2031)
4.1.3 Global Estradiol Transdermal System Sales Market Share by Type (2020-2031)
4.2 Global Estradiol Transdermal System Revenue by Type (2020-2031)
4.2.1 Global Estradiol Transdermal System Revenue by Type (2020-2025)
4.2.2 Global Estradiol Transdermal System Revenue by Type (2026-2031)
4.2.3 Global Estradiol Transdermal System Revenue Market Share by Type (2020-2031)
4.3 Global Estradiol Transdermal System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Estradiol Transdermal System Sales by Application (2020-2031)
5.1.1 Global Estradiol Transdermal System Sales by Application (2020-2025)
5.1.2 Global Estradiol Transdermal System Sales by Application (2026-2031)
5.1.3 Global Estradiol Transdermal System Sales Market Share by Application (2020-2031)
5.2 Global Estradiol Transdermal System Revenue by Application (2020-2031)
5.2.1 Global Estradiol Transdermal System Revenue by Application (2020-2025)
5.2.2 Global Estradiol Transdermal System Revenue by Application (2026-2031)
5.2.3 Global Estradiol Transdermal System Revenue Market Share by Application (2020-2031)
5.3 Global Estradiol Transdermal System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Estradiol Transdermal System Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Estradiol Transdermal System Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Estradiol Transdermal System Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Noven Therapeutics
6.4.1 Noven Therapeutics Company Information
6.4.2 Noven Therapeutics Description and Business Overview
6.4.3 Noven Therapeutics Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Noven Therapeutics Estradiol Transdermal System Product Portfolio
6.4.5 Noven Therapeutics Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Estradiol Transdermal System Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Vertical Pharmaceuticals
6.6.1 Vertical Pharmaceuticals Company Information
6.6.2 Vertical Pharmaceuticals Description and Business Overview
6.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vertical Pharmaceuticals Estradiol Transdermal System Product Portfolio
6.6.5 Vertical Pharmaceuticals Recent Developments/Updates
6.7 Perrigo Pharma International
6.7.1 Perrigo Pharma International Company Information
6.7.2 Perrigo Pharma International Description and Business Overview
6.7.3 Perrigo Pharma International Estradiol Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Perrigo Pharma International Estradiol Transdermal System Product Portfolio
6.7.5 Perrigo Pharma International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estradiol Transdermal System Industry Chain Analysis
7.2 Estradiol Transdermal System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estradiol Transdermal System Production Mode & Process Analysis
7.4 Estradiol Transdermal System Sales and Marketing
7.4.1 Estradiol Transdermal System Sales Channels
7.4.2 Estradiol Transdermal System Distributors
7.5 Estradiol Transdermal System Customer Analysis
8 Estradiol Transdermal System Market Dynamics
8.1 Estradiol Transdermal System Industry Trends
8.2 Estradiol Transdermal System Market Drivers
8.3 Estradiol Transdermal System Market Challenges
8.4 Estradiol Transdermal System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Allergan plc
Bayer
Noven Therapeutics
Mylan NV
Vertical Pharmaceuticals
Perrigo Pharma International
List of Tables
 Table 1. Global Estradiol Transdermal System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Estradiol Transdermal System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Estradiol Transdermal System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Estradiol Transdermal System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Estradiol Transdermal System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Estradiol Transdermal System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Estradiol Transdermal System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Estradiol Transdermal System Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Estradiol Transdermal System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Estradiol Transdermal System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Estradiol Transdermal System, Product Type & Application
 Table 12. Global Key Manufacturers of Estradiol Transdermal System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Estradiol Transdermal System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estradiol Transdermal System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Estradiol Transdermal System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Estradiol Transdermal System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Estradiol Transdermal System Sales Market Share by Region (2020-2025)
 Table 19. Global Estradiol Transdermal System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Estradiol Transdermal System Sales Market Share by Region (2026-2031)
 Table 21. Global Estradiol Transdermal System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Estradiol Transdermal System Revenue Market Share by Region (2020-2025)
 Table 23. Global Estradiol Transdermal System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Estradiol Transdermal System Revenue Market Share by Region (2026-2031)
 Table 25. North America Estradiol Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Estradiol Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Estradiol Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Estradiol Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Estradiol Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Estradiol Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Estradiol Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Estradiol Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Estradiol Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Estradiol Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Estradiol Transdermal System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Estradiol Transdermal System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Estradiol Transdermal System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Estradiol Transdermal System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Estradiol Transdermal System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Estradiol Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Estradiol Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Estradiol Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Estradiol Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Estradiol Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Estradiol Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Estradiol Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Estradiol Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Estradiol Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Estradiol Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Estradiol Transdermal System Sales (K Units) by Type (2020-2025)
 Table 51. Global Estradiol Transdermal System Sales (K Units) by Type (2026-2031)
 Table 52. Global Estradiol Transdermal System Sales Market Share by Type (2020-2025)
 Table 53. Global Estradiol Transdermal System Sales Market Share by Type (2026-2031)
 Table 54. Global Estradiol Transdermal System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Estradiol Transdermal System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Estradiol Transdermal System Revenue Market Share by Type (2020-2025)
 Table 57. Global Estradiol Transdermal System Revenue Market Share by Type (2026-2031)
 Table 58. Global Estradiol Transdermal System Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Estradiol Transdermal System Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Estradiol Transdermal System Sales (K Units) by Application (2020-2025)
 Table 61. Global Estradiol Transdermal System Sales (K Units) by Application (2026-2031)
 Table 62. Global Estradiol Transdermal System Sales Market Share by Application (2020-2025)
 Table 63. Global Estradiol Transdermal System Sales Market Share by Application (2026-2031)
 Table 64. Global Estradiol Transdermal System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Estradiol Transdermal System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Estradiol Transdermal System Revenue Market Share by Application (2020-2025)
 Table 67. Global Estradiol Transdermal System Revenue Market Share by Application (2026-2031)
 Table 68. Global Estradiol Transdermal System Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Estradiol Transdermal System Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Estradiol Transdermal System Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Allergan Company Information
 Table 76. Allergan Description and Business Overview
 Table 77. Allergan Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Allergan Estradiol Transdermal System Product
 Table 79. Allergan Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Estradiol Transdermal System Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Noven Therapeutics Company Information
 Table 86. Noven Therapeutics Description and Business Overview
 Table 87. Noven Therapeutics Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Noven Therapeutics Estradiol Transdermal System Product
 Table 89. Noven Therapeutics Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan Estradiol Transdermal System Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Vertical Pharmaceuticals Company Information
 Table 96. Vertical Pharmaceuticals Description and Business Overview
 Table 97. Vertical Pharmaceuticals Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Vertical Pharmaceuticals Estradiol Transdermal System Product
 Table 99. Vertical Pharmaceuticals Recent Developments/Updates
 Table 100. Perrigo Pharma International Company Information
 Table 101. Perrigo Pharma International Description and Business Overview
 Table 102. Perrigo Pharma International Estradiol Transdermal System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Perrigo Pharma International Estradiol Transdermal System Product
 Table 104. Perrigo Pharma International Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Estradiol Transdermal System Distributors List
 Table 108. Estradiol Transdermal System Customers List
 Table 109. Estradiol Transdermal System Market Trends
 Table 110. Estradiol Transdermal System Market Drivers
 Table 111. Estradiol Transdermal System Market Challenges
 Table 112. Estradiol Transdermal System Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Estradiol Transdermal System
 Figure 2. Global Estradiol Transdermal System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Estradiol Transdermal System Market Share by Type: 2024 & 2031
 Figure 4. 0.025 mg per day Product Picture
 Figure 5. 0.0375 mg per day Product Picture
 Figure 6. 0.05 mg per day Product Picture
 Figure 7. 0.075 mg per day Product Picture
 Figure 8. 0.1 mg per day Product Picture
 Figure 9. Global Estradiol Transdermal System Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Estradiol Transdermal System Market Share by Application: 2024 & 2031
 Figure 11. Hot Flashes
 Figure 12. Prevention of Postmenopausal Osteoporosis
 Figure 13. Treatment of Hypoestrogenism
 Figure 14. Moderate-To-Severe Vasomotor Symptoms
 Figure 15. Others
 Figure 16. Global Estradiol Transdermal System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Estradiol Transdermal System Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Estradiol Transdermal System Sales (2020-2031) & (K Units)
 Figure 19. Global Estradiol Transdermal System Average Price (USD/Unit) & (2020-2031)
 Figure 20. Estradiol Transdermal System Report Years Considered
 Figure 21. Estradiol Transdermal System Sales Share by Manufacturers in 2024
 Figure 22. Global Estradiol Transdermal System Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Estradiol Transdermal System Players: Market Share by Revenue in Estradiol Transdermal System in 2024
 Figure 24. Estradiol Transdermal System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Estradiol Transdermal System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Estradiol Transdermal System Sales Market Share by Country (2020-2031)
 Figure 27. North America Estradiol Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Estradiol Transdermal System Sales Market Share by Country (2020-2031)
 Figure 31. Europe Estradiol Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Estradiol Transdermal System Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Estradiol Transdermal System Revenue Market Share by Region (2020-2031)
 Figure 39. China Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Estradiol Transdermal System Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Estradiol Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Estradiol Transdermal System Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Estradiol Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Estradiol Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Estradiol Transdermal System by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Estradiol Transdermal System by Type (2020-2031)
 Figure 61. Global Estradiol Transdermal System Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Estradiol Transdermal System by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Estradiol Transdermal System by Application (2020-2031)
 Figure 64. Global Estradiol Transdermal System Price (USD/Unit) by Application (2020-2031)
 Figure 65. Estradiol Transdermal System Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Estradiol Patches Market Research Report 2024
Global HRT Patches Market Research Report 2024
Global Estradiol Gel Market Research Report 2024
Global Transdermal Contraceptive Patch Market Research Report 2024
Estradiol Norethindrone Acetate Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Conjugated Estrogens Tablet Market Research Report 2024
Global Hormones Contraceptive Patch Market Research Report 2024
Estrogen Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menstrual Heat Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Testosterone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estradiol Dydrogesterone Tablets Market Research Report 2025
Global Estradiol Market Insights Forecast to 2030
Hormone Replacement Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hormone Replacement Therapy HRT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estradiol Norethindrone Acetate Tablets Market Research Report 2024
Global Estradiol API Market Research Report 2025
Global Transdermal Drug Delivery System Market Insights Forecast to 2030
Global Testosterone Transdermal System Market Research Report 2025
Hormone Replacement Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions